Our results confirm transcriptional dysregulation of TAF1 in our NPC cell model, in NPC‐secreted EVs, and in peripheral blood in patients with XDP and female carriers compared with neurologically healthy controls. The gene discussed is TAF1; the disease is nasopharyngeal carcinoma.